Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.33 |
| ▸ | CA2 | P00918 | 4/20 | 0.33 |
| ▸ | CA9 | Q16790 | 4/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL889674 | 0.84 | LGALS8 (0.35) | — | |
| SCHEMBL24974809 | 0.75 | L3MBTL1 (0.36) | — | |
| SCHEMBL22227380 | 0.75 | CA1 (0.32) | CA1CA2CA9 | |
| SCHEMBL5523046 | 0.75 | CA1 (0.32) | CA1CA2CA9MAPK1 | |
| SCHEMBL14690760 | 0.70 | GAA (0.50) | CA1CA2CA9MAPK1 | |
| SCHEMBL2039570 | 0.70 | GAA (0.50) | CA1CA2CA9MAPK1 | |
| SCHEMBL10388472 | 0.70 | GAA (0.50) | CA1CA2CA9MAPK1 | |
| SCHEMBL14690963 | 0.70 | GAA (0.50) | CA1CA2CA9MAPK1 | |
| SCHEMBL15352893 | 0.70 | GAA (0.50) | CA1CA2CA9MAPK1 | |
| SCHEMBL15353156 | 0.70 | GAA (0.50) | CA1CA2CA9MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120009260-A1 | NANOPARTICLE FILM DELIVERY SYSTEMS | AQUESTIVE THERAPEUTICS, INC. | 2012-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120009260-A1 | NANOPARTICLE FILM DELIVERY SYSTEMS | CD63, DSTN, EPCAM | CA1 3159/4885CA2 3865/4885CA9 1846/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.